info@ceoworld.biz
Saturday, April 20, 2024
CEOWORLD magazine - Latest - CEO Advisory - Meet The 8 Billionaires Of The B. Braun Melsungen Family

CEO Advisory

Meet The 8 Billionaires Of The B. Braun Melsungen Family

B. Braun Melsungen AG, a German pharmaceutical and medtech company, has turned eight of Ludwig Georg Braun’s relatives, including his 5 children and 3 of his cousin Barbara Luedicke’s children, into billionaires.

It all started way back in June 23, 1839, when when Julius Wilhelm Braun, Ludwig’s great-great-grandfather, purchased Rosen-Apotheke, a small pharmacy in Melsungen, Germany.

Julius’ eldest son Bernhard Braun, who took over in 1864, began manufacturing pharmaceutical products like migraine sticks and plasters.

Later, in 1977, when Ludwig Georg Braun took over the family business, its sales were only $ 24 million.

Today B. Braun Melsungen is one of the world´s leading healthcare suppliers, has more than $5 billion in sales and employs 50,000 people. B. Braun Melsungen AG is still owned by the Braun family.

Here, we break down the names and net worths of all 8 B. Braun Melsungen AG billionaires:

[Children of Ludwig Georg Braun]

1) Otto Philipp Braun
Stake: 23%
Estimated net worth: $3.5 billion

2) Karl Friedrich Braun
Stake: 10%
Estimated net worth: $1.5 billion

3) Anna Maria Braun
Stake: 10%
Estimated net worth: $ 1.5 billion

4) Johanna Braun
Stake: 10%
Estimated net worth: $ 1.5 billion

5) Ludwig Theodore Braun
Stake: 9.7%
Estimated net worth: $ 1.44 billion

[Children of  Barbara Luedicke]

6) Bernhard Sebastian Braun-Luedicke
Stake: 11.7%
Estimated net worth: $ 1.7 billion

7) Eva Maria Braun-Luedicke
Stake: 11.7%
Estimated net worth: $ 1.7 billion

8) Friederike Braun-Luedicke
Stake: 11.7%
Estimated net worth: $ 1.7 billion


Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.


Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
SUBSCRIBE NEWSLETTER
CEOWORLD magazine - Latest - CEO Advisory - Meet The 8 Billionaires Of The B. Braun Melsungen Family
Prof. Dr. Amarendra Bhushan Dhiraj
Prof. Dr. Amarendra Bhushan Dhiraj is a publishing executive and economist who is the CEO and editor-in-chief of The CEOWORLD magazine, one of the world’s most influential and recognized global news publications. Additionally, he serves as the chair of the advisory board for the CEOWORLD magazine. He received his Ph.D. in Finance and Banking from the European Global School, Paris, France. He earned his Doctoral Degree in Chartered Accountancy from the European International University Paris, France, and a Doctorate in Business Administration from Kyiv National University of Technologies and Design (KNUTD), Ukraine. Dr. Amarendra also holds a Master of Business Administration degree in International Relations and Affairs from the American University of Athens, Alabama, United States.


Prof. Dr. Amarendra Bhushan Dhiraj is CEO and editor-in-chief of CEOWORLD magazine. You can follow him on LinkedIn, Facebook, Twitter.